Statistics on Biotechnology Use  
Results by sector of operation
Company sector.  Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production
Unidades: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1.133,564,212,358,
%Companies according to biotechnology used: Genetic code,32,42,22,20,
%Companies according to biotechnology used: Functional units,41,48,40,30,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,27,33,24,19,
%Companies according to biotechnology used: Bioprocesses,48,41,47,60,
%Companies according to biotechnology used: Sub-cellular organisms,8,11,8,4,
%Companies according to biotechnology used: Bio-computing,21,31,13,11,
%Companies according to biotechnology used: Nanobiotechnology,14,18,16,7,
%Companies according to biotechnology used: Other,13,13,15,12,
%Company by field(s) of ultimate application of biotechnology use: Human Health,50,70,42,23,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,19,21,18,17,
%Company by field(s) of ultimate application of biotechnology use: Food products,29,22,30,40,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,21,19,25,23,
%Company by field(s) of ultimate application of biotechnology use: Environment,13,11,20,10,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,13,18,12,
Personnel in R&D in biotechnology (no. of persons),10.706,5.968,1.806,2.932,
Personnel in R&D in biotechnology (no. of persons): Researchers,6.227,3.765,994,1.467,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.479,2.202,812,1.464,
Personnel in R&D in biotechnology (no. of persons): women,5.795,3.402,884,1.510,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3.269,2.049,503,717,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.527,1.353,381,793,
Personnel in R&D in biotechnology (FTE),7.716,4,4.708,3,1.165,8,1.842,3,
Personnel in R&D in biotechnology (FTE): Researchers,4.603,1,2.952,5,690,5,960,1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3.113,3,1.755,8,475,3,882,2,
Personnel in R&D in biotechnology (FTE): women,4.292,9,2.666,584,9,1.042,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.446,4,1.592,2,352,1,502,1,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.846,5,1.073,7,232,8,539,9,
Internal expenditure on R&D (thousands of euros),616.053,401.754,86.676,127.622,
1) By nature of the expense: Current expenses,574.245,371.873,81.601,120.772,
1.1) Remuneration to researchers,221.741,145.148,33.906,42.688,
1.2) Remuneration to technicians and assistants,102.464,53.306,17.155,32.002,
1.3) Other current expenses,250.041,173.419,30.540,46.082,
2) By nature of the expense: Capital expenses,41.808,29.882,5.075,6.851,
2.1) Land and buildings,5.359,3.592,486,1.281,
2.2) Equipment and instruments,29.489,20.787,4.073,4.630,
2.3) Acquisition of specific R+D software,2.306,1.549,139,618,
2.4) Otros productos de propiedad intelectual específicos para I+D,4.654,3.955,377,322,
1) By origin of the funds: National funds,511.960,311.167,76.048,124.744,
1.1) Own funds,382.335,232.410,47.954,101.970,
1.2) From companies,45.024,25.073,10.783,9.168,
1.3) Public Administration funds,72.387,45.317,16.642,10.428,
1.4) From Universities,363,363,0,.,
1.5) From non profit private institutions,11.851,8.005,669,3.178,
1) By origin of the funds: Foreign funds,104.093,90.587,10.628,2.879,
2.1) From EU programmes,21.825,13.669,5.814,2.342,
2.2) Other foreign funds,82.269,76.918,4.813,537,
Purchase of R&D services in biotechnology (thousands of euros),144.342,91.533,26.448,26.360,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,70.458,43.549,11.885,15.023,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,73.885,47.984,14.563,11.337,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,48,57,46,35,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,12,14,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,15,15,16,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,12,12,18,11,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets,16,18,21,9,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels,16,20,18,9,
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception,16,17,18,11,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,40,43,26,
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost,49,56,47,39,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,18,17,24,16,
% Companies that have requested biotechnology patents,16,24,8,7,
Number of patents requested,633,474,71,88,
% Companies with income of an international origin related to biotechnological activities,24,32,7,15,5,15,2,
% Turnover representing income of an international origin related to biotechnological activities,1,4,9,0,1,2,6,
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU,57,3,35,5,37,3,77,6,
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries,42,7,64,5,62,7,22,4,
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services,82,3,91,3,80,2,74,3,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,16,5,7,1,.,25,6,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,1,1,19,6,0,1,
% Income of an international origin related with activities according to the classification: Other,0,3,0,6,0,2,0,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute